UNCY
UNCY
NASDAQ · Biotechnology

Unicycive Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.17
+0.22 (+2.77%)
As of May 16, 2:10 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -23.3% upside
Low Target $3.63
Average Target $6.27
High Target $7.20
Current Price $8.17
Current
$8.17
Target
$6.27
$3.63 $6.27 avg $7.20
Scenario Analysis
Bear Case
$3.63
-55.6%
Low target
Base Case
$6.27
-23.3%
Avg target
Bull Case
$7.20
+-11.9%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$11.00
-25.7% from high
52-Week Low
$3.71
+120.2% from low
Target vs 52W High
$6.27
-43.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%